Pregnancy Complications Clinical Trials in Washington D.C., District of Columbia

3 studies are recruiting for pregnancy complications in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Navigating Pregnancy and Parenthood With Lyme Disease

    This is a mixed methods study exploring the experiences of pregnancy and parenting among participants with Lyme disease. Eligible participants will have been diagnosed with Lyme disease (LD), post-treatment Lyme disease syndrome (PTLDS), and/or chronic Lyme (CL) either during or before a prior preg…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Children's National Hospital, Washington D.C., District of Columbia
    Run by
    Children's National Research Institute

    See if you can join NCT06397794 on ClinicalTrials.gov

  2. Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure

    The purpose of this pilot study is to assess the feasibility of longitudinal neurodevelopmental evaluation of fetuses and infants exposed to Lyme disease in utero. Participants with Lyme disease or Post-Treatment Lyme Disease Syndrome (PTLDS) will be recruited during pregnancy. Pregnancies will be …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Children's National Hospital, Washington D.C., District of Columbia
    Run by
    Children's National Research Institute

    See if you can join NCT06026969 on ClinicalTrials.gov

  3. Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

    The goal of this observational registry is to evaluate the safety and outcomes of pregnancy and lactation in women with Fabry disease who are exposed to pegunigalsidase alfa within 30 days prior to conception and/or during pregnancy and lactation. The main objectives are to: * Assess pregnancy outc…

    Stage
    Not phased
    Ages
    Any age
    Site
    No physical study sites - Decentralized, web-based registry, Washington D.C., District of Columbia
    Locations
    5 in total
    Run by
    Chiesi Farmaceutici S.p.A.

    See if you can join NCT06941025 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.